Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AmBisome vs Fluconazole for IFI Prevention in Liver Transplant Recipients
NCT00001107Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amphotericin b in invasive fungal infection (IFI), candidiasis, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
amphotericin b
03
Conditions
invasive fungal infection (IFI)candidiasis
Beyond the preview
Go deeper on NCT00001107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001107.